PubMed, 46(2), 123128
Drug-specific findings showed that liraglutide, albiglutide, and dulaglutide were associated with a lower risk of MACE, myocardial infarction, and stroke, with moderate or high certainty
Some have thyroid dysfunction that no conventional lab caught because only TSH was tested
7A, C), to an extent ( p = 0.20)
Cost Comparison Table Insurance Coverage Saxenda: FDA-approved for weight loss Some plans cover with prior authorization May have quantity limits or step therapy requirements Ozempic: FDA-approved for diabetes, not weight loss Often covered for diabetic patients Rarely covered for weight loss alone Wegovy: FDA-approved for weight loss Coverage varies widely Many plans exclude weight loss medications Cost Efficiency When comparing cost per outcome: Saxenda: At $200/month for 12 months ($2,400) producing 15-18 pounds loss = ~$133-160 per pound lost Semaglutide: At $199/month for 12 months ($2,388) producing 30-35 pounds loss = ~$68-80 per pound lost Semaglutide provides substantially better value when considering weight loss achieved per dollar spent
If it is unclear what action to take, refer to the prescription guide or consult the doctor, with a focus on returning to a regular treatment schedule in the future
